Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Bergman

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Nucleosides, Nucleotides & Nucleic Acids|December 2, 2004
Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinosylcytosine (ara-C) in leukemia and solid tumor cell linesA M Bergman, C M Kuiper, F Myhren, et al.
Medical Physics|November 26, 1998
Technique to obtain positron emission mammography images in registration with x-ray mammogramsA M Bergman, C J Thompson, K Murthy, et al.
Biochemical Pharmacology|February 28, 2007
The synergistic interaction of gemcitabine and cytosine arabinoside with the ribonucleotide reductase inhibitor triapine is schedule dependentJ Sigmond, J A E Kamphuis, A C Laan, et al.
Seminars in Oncology|August 1, 1995
Interaction between cisplatin and gemcitabine in vitro and in vivoG J Peters, A M Bergman, V W Ruiz van Haperen, et al.
International Journal of Oncology|December 7, 2002
Effect of gemcitabine and cis-platinum combinations on ribonucleotide and deoxyribonucleotide pools in ovarian cancer cell linesC J A Van Moorsel, K Smid, D A Voorn, et al.
Advances in Experimental Medicine and Biology|May 23, 1998
Cross-resistance of the gemcitabine resistant human ovarian cancer cell line AG6000 to standard and investigational drugsA M Bergman, H M Pinedo, V W Ruiz van Haperen, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2000
Cross-resistance in the 2',2'-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000 to standard and investigational drugsA M Bergman, G Giaccone, C J van Moorsel, et al.
Radiology|February 7, 2001
Positron emission mammographic instrument: initial resultsK Murthy, M Aznar, A M Bergman, et al.
Seminars in Oncology|April 1, 1997
Combination chemotherapy studies with gemcitabineC J van Moorsel, G Veerman, A M Bergman, et al.
Anti-Cancer Drugs|September 7, 1999
Selective cell kill of the combination of gemcitabine and cisplatin in multilayered postconfluent tumor cell culturesJ M Padrón, C J van Moorsel, A M Bergman, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Nucleosides, Nucleotides & Nucleic Acids|December 2, 2004
Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinosylcytosine (ara-C) in leukemia and solid tumor cell linesA M Bergman, C M Kuiper, F Myhren, et al.
Medical Physics|November 26, 1998
Technique to obtain positron emission mammography images in registration with x-ray mammogramsA M Bergman, C J Thompson, K Murthy, et al.
Biochemical Pharmacology|February 28, 2007
The synergistic interaction of gemcitabine and cytosine arabinoside with the ribonucleotide reductase inhibitor triapine is schedule dependentJ Sigmond, J A E Kamphuis, A C Laan, et al.
Seminars in Oncology|August 1, 1995
Interaction between cisplatin and gemcitabine in vitro and in vivoG J Peters, A M Bergman, V W Ruiz van Haperen, et al.
International Journal of Oncology|December 7, 2002
Effect of gemcitabine and cis-platinum combinations on ribonucleotide and deoxyribonucleotide pools in ovarian cancer cell linesC J A Van Moorsel, K Smid, D A Voorn, et al.
Advances in Experimental Medicine and Biology|May 23, 1998
Cross-resistance of the gemcitabine resistant human ovarian cancer cell line AG6000 to standard and investigational drugsA M Bergman, H M Pinedo, V W Ruiz van Haperen, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2000
Cross-resistance in the 2',2'-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000 to standard and investigational drugsA M Bergman, G Giaccone, C J van Moorsel, et al.
Radiology|February 7, 2001
Positron emission mammographic instrument: initial resultsK Murthy, M Aznar, A M Bergman, et al.
Seminars in Oncology|April 1, 1997
Combination chemotherapy studies with gemcitabineC J van Moorsel, G Veerman, A M Bergman, et al.
Anti-Cancer Drugs|September 7, 1999
Selective cell kill of the combination of gemcitabine and cisplatin in multilayered postconfluent tumor cell culturesJ M Padrón, C J van Moorsel, A M Bergman, et al.
Pageof 5